Procaine
| Procaine | |
|---|---|
| Salts [] | |
|---|---|
| Procaine pentaborate | |
| Procaine hydrochloride | |
| Procaine phosphate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 236.31 g/mol [1] |
| Appearance | Anhydrous plates, tables from ligroin or ether [1] |
| Melting point | 61 °C [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of nitroxides. [1] |
| Solubility | 9450 mg/L (at 30 °C) [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H20N2O2 |
| IUPAC name | 2-(diethylamino)ethyl 4-aminobenzoate |
| SMILES | CCN(CC)CCOC(=O)C1=CC=C(C=C1)N |
| InChI | InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3 |
| InChIKey | MFDFERRIHVXMIY-UHFFFAOYSA-N |
| CAS number | 59-46-1 |
| UNII | 4Z8Y51M438 |
| PubChem CID | 4914 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 40–84 seconds |
| Metabolism | Hydrolysis by plasma esterases |
| Excretion | Renal |
| Routes of administration | Parenteral |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - oral: 350 mg/kg - ip: 124 mg/kg - sc: 300 mg/kg - iv: 45 mg/kg - Oral: 350 mg/kg Rat: - sc: 600 mg/kg [1] |
Procaine (also known as Spinocaine, Duracaine, Procain, Vitamin H3, Nissocaine, Novocaine, Procaine, base, Procaina, Scurocaine or Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester) is a sodium channel blocker and stimulant substance of the aniline class.
Chemistry
Salts []
Stereochemistry []
Procaine is achiral.
Druglikeness
Lipinski's rule of five
Procaine matches Lipinski's rule of five.Reagents
There are currently 10 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | very light yellow | |
| Mandelin | deep orange | |
| Liebermann | no color change | |
| Froehde | no color change | |
| Robadope | light yellow | |
| Ehrlich | orange | |
| Hofmann | yellow | |
| Scott | weak light blue | |
| Morris | greenish / blueish ring |
Pharmacology
ATC Classification
- cardiovascular system (C)
- vasoprotectives (C05)
- agents for treatment of hemorrhoids and anal fissures for topical use (C05A)
- local anesthetics (C05AD)
- procaine (C05AD05)
- nervous system (N)
- anesthetics (N01)
- anesthetics, local (N01B)
- esters of aminobenzoic acid (N01BA)
- (N01BA02)
- procaine (N01BA02)
- sensory organs (S)
- ophthalmologicals (S01)
- local anesthetics (S01H)
- local anesthetics (S01HA)
- procaine (S01HA05)
MeSH Classification
- anesthetics, local (M0001169)
Mechanism of action []
Procaine acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Procaine has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex. [1]
Interactions []
Medical side effects []
45 side effects listed on drug labels in SIDER 4.1 (procaine).
- Acidosis
- Angioedema
- Anxiety
- Apnoea
- Arachnoiditis
- Cardiac output decreased
- Dizziness
- Syncope
- Somnolence
- Oedema
- Body temperature increased
- Cardiac arrest
- Atrioventricular block
- Hypersensitivity
- Hypertension
- Hypotension
- Laryngeal oedema
- Meningism
- Nausea
- Nervousness
- Tension
- Pruritus
- Convulsion
- Sneezing
- Shock
- Loss of consciousness
- Tachycardia
- Tinnitus
- Tremor
- Erythema
- Urticaria
- Vasodilation procedure
- Vomiting
- Ventricular arrhythmia
- Agitation
- Excitement
- Respiratory arrest
- Paralysis
- Pseudocholinesterase deficiency
- Post lumbar puncture syndrome
- Anaphylactic shock
- Anaphylactoid reaction
- Vision blurred
- Bradycardia
- Hyperhidrosis
Subjective effects []
Experience reports
Legal status []
- Australia: Procaine is a Schedule 4.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4914, Procaine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4914
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Procaine. UNII: 4Z8Y51M438. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4Z8Y51M438
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:02:05 |
| drugspro | ok | 2026-11-20 14:02:01 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:02:01 |
| gsrs | ok | 2026-11-20 14:02:03 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014859) | 2026-11-20 14:02:01 |
| kegg | ok | 2026-11-20 14:02:03 |
| pubchem | ok | 2026-11-20 14:02:00 |
| ok | 2026-11-20 14:02:01 | |
| sider | ok | 2026-11-20 14:02:01 |
| structure | ok | 2026-11-20 14:02:01 |
| wikipedia | ok | 2026-11-20 14:02:01 |